retatrutide clinical benefits vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Perceived benefits of treatment for

Users exploring retatrutide protocols should anticipate dry mouth as a potential side effect and plan accordingly

AJMC, 18 January 2021: [11] Digital health companies making a long-term play for the $100B weight loss drug market

During consultations, we take into account the patients medical history, including any history of thyroid cancer or stomach disorders

These symptoms are typically most pronounced during the initial weeks of treatment or following dose increases, as the body adjusts to the medication's effects on gastric emptying and satiety signalling

Key Takeaways Retatrutide is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors developed by Eli Lilly Phase 2 results: Up to 24.2% body weight loss at the highest dose (12 mg) over 48 weeks, published in the New England Journal of Medicine Phase 3 TRIUMPH trials: Ongoing across 5 indications including obesity, type 2 diabetes, and MASH (fatty liver disease)